Skip to main content
. 2023 Jan 7;12(2):505. doi: 10.3390/jcm12020505
Aes adverse events
ALT alanine transaminase
AST aspartate transaminase
BC breast cancer
CIPN chemotherapy-induced peripheral neuropathy
ECOG Eastern Cooperative Oncology Group
EORTC QLQ-CIPN20 the European Organization for the Research and Treatment of Cancer-Chemotherapy-induced peripheral neuropathy 20
HGWD Huangqi Guizhi Wuwu decoction
IL-4 interleukin-4
iNOS inducible nitric oxide synthase
ITT intention-to-treat
nab-PTX albumin-bound paclitaxel
NCI-CTCAE Common terminology criteria for adverse events
PN peripheral neuropathy;
PS performance status;
PTX paclitaxel
TNBC triple negative breast cancer
TRAEs treatment-related adverse events
ULN upper limit of normal